ALS Ltd (ALQ):企業の財務・戦略的SWOT分析

◆英語タイトル:ALS Ltd (ALQ) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C9204
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:51
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

ALS Ltd (ALQ) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

ALS Limited (ALS), formerly, Campbell Brothers Limited is a diversified testing service provider. The company provides testing services in the areas of minerals, life sciences, energy and industrial. It provides offers chemical and laboratory services, technical testing and inspection services supporting mining and mineral exploration, commodity certification, environmental monitoring, equipment maintenance, food and pharmaceutical quality assurance and industrial operations. The company serves asset owners, operators, mining, constructors and equipment manufacturers in the power, oil and gas, petrochemical, minerals processing, water, infrastructure and transportation industries. ALS is headquartered in Brisbane, Queensland, Australia.

ALS Ltd Key Recent Developments

Nov 01,2018: Advance Gold reports additional information on phase 2 drilling
Oct 31,2018: American Creek reports that JV partner Tudor Gold continues to grow Treaty Creek
Oct 29,2018: Grande Portage Resources announces drill hole from its recently completed Herbert Gold project located in southeast Alaska
Oct 29,2018: Rover Metals announces results from its September 2018 soil geochemistry survey at its Cabin Lake Gold Project
Oct 25,2018: Wildsky Resources receives final assay results from 2018 drilling program

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
ALS Ltd – Key Facts 6
ALS Ltd – Key Employees 7
ALS Ltd – Key Employee Biographies 8
ALS Ltd – Major Products and Services 9
ALS Ltd – History 10
ALS Ltd – Company Statement 12
ALS Ltd – Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Section 2 – Company Analysis 16
Company Overview 16
ALS Ltd – Business Description 17
Business Segment: Commodities 17
Overview 17
Performance 17
Business Segment: Discontinued operation- Oil & Gas 17
Overview 17
Business Segment: Industrial 17
Overview 17
Performance 17
Business Segment: Life Sciences 17
Overview 17
Performance 18
Geographical Segment: Australia 18
Performance 18
Geographical Segment: Canada 18
Performance 18
Geographical Segment: Others 18
Performance 18
Geographical Segment: The US 18
Performance 18
ALS Ltd – Corporate Strategy 19
ALS Ltd – SWOT Analysis 20
SWOT Analysis – Overview 20
ALS Ltd – Strengths 20
ALS Ltd – Weaknesses 21
ALS Ltd – Opportunities 22
ALS Ltd – Threats 23
ALS Ltd – Key Competitors 24
Section 3 – Company Financial Ratios 25
Financial Ratios – Capital Market Ratios 25
Financial Ratios – Annual Ratios 26
Performance Chart 29
Financial Performance 29
Financial Ratios – Interim Ratios 30
Financial Ratios – Ratio Charts 31
ALS Ltd, Recent Deals Summary 32
Section 4 – Company’s Recent Developments 33
Nov 08, 2018: Hammer Metals announces Millennium north metallurgical tests achieve +90% copper and cobalt recoveries 33
Nov 01, 2018: Advance Gold reports additional information on phase 2 drilling 34
Oct 31, 2018: American Creek reports that JV partner Tudor Gold continues to grow Treaty Creek 35
Oct 29, 2018: Rover Metals announces results from its September 2018 soil geochemistry survey at its Cabin Lake Gold Project 36
Oct 29, 2018: Grande Portage Resources announces drill hole from its recently completed Herbert Gold project located in southeast Alaska 37
Oct 22, 2018: Conico: Excellent progress on Mt Thirsty PFS work 38
Oct 22, 2018: Benchmark makes two new discoveries and awaits assay results 41
Oct 09, 2018: Silver Range samples high grade gold at Tree River Project 42
Oct 05, 2018: New Dimension reports updated mineral resource estimate for Las Calandrias Project, Santa Cruz Province, Argentina 43
Sep 20, 2018: Barsele Expansion drill hole SKI18004 at the Skiråsen Zone intersects Nine Mineralized Intervals 46
Section 5 – Appendix 47
Methodology 47
Ratio Definitions 47
About GlobalData 51
Contact Us 51
Disclaimer 51

List of Tables
ALS Ltd, Key Facts 6
ALS Ltd, Key Employees 7
ALS Ltd, Key Employee Biographies 8
ALS Ltd, Major Products and Services 9
ALS Ltd, History 10
ALS Ltd, Subsidiaries 14
ALS Ltd, Key Competitors 24
ALS Ltd, Ratios based on current share price 25
ALS Ltd, Annual Ratios 26
ALS Ltd, Annual Ratios (Cont...1) 27
ALS Ltd, Annual Ratios (Cont...2) 28
ALS Ltd, Interim Ratios 30
ALS Ltd, Recent Deals Summary 32
Currency Codes 47
Capital Market Ratios 47
Equity Ratios 48
Profitability Ratios 48
Cost Ratios 49
Liquidity Ratios 49
Leverage Ratios 50
Efficiency Ratios 50

List of Figures
ALS Ltd, Performance Chart (2014 - 2018) 29
ALS Ltd, Ratio Charts 31

★海外企業調査レポート[ALS Ltd (ALQ):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • E*Trade Financial Corporation:企業のM&A・事業提携・投資動向
    E*Trade Financial Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's E*Trade Financial Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Culp Inc (CULP):企業の財務・戦略的SWOT分析
    Culp Inc (CULP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • PT Paninvest Tbk:企業の戦略・SWOT・財務情報
    PT Paninvest Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Paninvest Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Centre for Drug Research and Development-製薬・医療分野:企業M&A・提携分析
    Summary Centre for Drug Research and Development (CDRD) is a drug development and commercialization center that provides infrastructure to transform basic health research in academic institutions and early-stage therapeutic technologies into new medicines. The center offers target validation, screen …
  • Eupraxia Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Eupraxia Pharmaceuticals Inc (Eupraxia Pharma) is a drug development company that offers pain management solutions. The company’s technology encapsulates pharmaceutical micro particles in a polymer shell which helps to extend drug release from days to months. Its pipeline products include EP …
  • Ayala Land Inc:戦略・SWOT・企業財務分析
    Ayala Land Inc - Strategy, SWOT and Corporate Finance Report Summary Ayala Land Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Terumo BCT Inc:企業の戦略的SWOT分析
    Terumo BCT Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • NOW Health Group Inc:企業の戦略・SWOT・財務情報
    NOW Health Group Inc - Strategy, SWOT and Corporate Finance Report Summary NOW Health Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • AGRANA Beteiligungs-AG:企業の戦略・SWOT・財務分析
    AGRANA Beteiligungs-AG - Strategy, SWOT and Corporate Finance Report Summary AGRANA Beteiligungs-AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Verde Science Inc-石油・ガス分野:企業M&A・提携分析
    Summary Verde Science Inc (Verde Science), formerly Rango Energy Inc is a medical technology company that offers bioprocess solutions. The company offers research and development services with expertise in bioprocess technology, molecular virology and immunology, nanotechnology, pharmacology and med …
  • Max-Delbruck-Centrum fur Molekulare Medizin (MDC)-製薬・医療分野:企業M&A・提携分析
    Summary Max-Delbruck-Centrum fur Molekulare Medizin (MDC) is a biomedical research centre. The centre offers molecular biology research services, signal transduction research, development biology research, molecular immunology and gene therapy research, non coding RNAs research, cytoplasmic gene reg …
  • Mapletree Investments Pte Ltd:企業の戦略的SWOT分析
    Mapletree Investments Pte Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • John B. Sanfilippo & Son Inc:企業の戦略・SWOT・財務分析
    John B. Sanfilippo & Son Inc - Strategy, SWOT and Corporate Finance Report Summary John B. Sanfilippo & Son Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • BioCision LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary BioCision LLC (BioCision) is a life science research and development company that develops products and solutions for process standardization. The company provides products such as cell cryopreservation systems, ice-free cooling systems, tube and plate temperature management systems, cell th …
  • Stockmann plc (STCBV):企業の財務・戦略的SWOT分析
    Stockmann plc (STCBV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • bioMerieux SA.:企業のM&A・事業提携・投資動向
    bioMerieux SA. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's bioMerieux SA. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Lockheed Martin Aeronautics Company:企業の戦略・SWOT・財務分析
    Lockheed Martin Aeronautics Company - Strategy, SWOT and Corporate Finance Report Summary Lockheed Martin Aeronautics Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Al Safeer Group of Companies:企業の戦略・SWOT・財務情報
    Al Safeer Group of Companies - Strategy, SWOT and Corporate Finance Report Summary Al Safeer Group of Companies - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • WEG SA:戦略・SWOT・企業財務分析
    WEG SA - Strategy, SWOT and Corporate Finance Report Summary WEG SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • EndoChoice Inc:医療機器:M&Aディール及び事業提携情報
    Summary EndoChoice Inc (EndoChoice), a subsidiary of Boston Scientific Corp is a medical device company that develops and commercializes medical devices, diagnostic equipment, infection control products and endoscopic imaging systems. The company’s infection control products comprise biopsy valves, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆